Insurer Independent Health and a subsidiary, DxID, are under fire from the U.S. Department of Justice for allegedly submitting unsupported diagnosis codes to inflate Medicare Advantage reimbursements.
The alleged violation of the federal False Claims Act would have enabled the companies to receive payments from Medicare greater than to what they were entitled.
